NDC 51672-2085-01 - Childrens Loratadine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2085
- Requested NDC
- 51672-2085-01
- Package NDCs from labels
- 51672-2085-8, 51672-2085-4, 51672-2085-5, 51672-2085-1, 51672-2085-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Children's Loratadine | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-07-14 | HUMAN OTC DRUG LABEL |
| Childrens Loratadine - Aidarex Pharmaceuticals LLC | Aidarex Pharmaceuticals LLC | 2012-09-28 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2085-1 | Childrens Loratadine | 1 in 1 CARTON | SOLUTION | 1 | 4 | |
| 51672-2085-1 | Childrens Loratadine | 240 mL in 1 BOTTLE | SOLUTION | 240 | 4 | |
| 51672-2085-4 | Childrens Loratadine | 1 in 1 CARTON | SOLUTION | 1 | 4 | |
| 51672-2085-4 | Childrens Loratadine | 60 mL in 1 BOTTLE | SOLUTION | 60 | 4 | |
| 51672-2085-5 | Childrens Loratadine | 180 mL in 1 BOTTLE | SOLUTION | 180 | 4 | |
| 51672-2085-5 | Childrens Loratadine | 1 in 1 CARTON | SOLUTION | 1 | 4 | |
| 51672-2085-8 | Childrens Loratadine | 120 mL in 1 BOTTLE | SOLUTION | 120 | 4 | |
| 51672-2085-8 | Childrens Loratadine | 1 in 1 CARTON | SOLUTION | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2085 | CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 8 package rows | 20241222_12c8066a-3429-481e-b63a-7ea2b439a170.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2085-8 | ML - Milliliter | 51672-2085 | 5184de2c-9fbe-4799-98ab-e9575e711178 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GenTeal Tears (Moderate) | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | Alcon Laboratories, Inc. | a2992597-3490-6a5c-be45-2b6fa15e1547 | 2023-12-15 | Warnings | PDC6A3C0OX |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | db3a6c68-320b-46b0-83fa-6c29297a84a6 | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | Alcon Research Ltd | 14916d2c-a63d-491e-bd91-a61f300af38a | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane Lubricant | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 15bc06ec-f3dc-3180-ca1a-106769a770ea | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane ULTRA | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a5c1c194-3db5-4f18-9cd1-97f7f84c3cff | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 7eaa93ca-c843-4c89-921b-c76659410dce | 2023-12-14 | Warnings | 6DC9Q167V3 |
| GenTeal Tears Gel Drops | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 84388a75-9d11-48ce-bf5a-88f0580d2d03 | 2023-12-14 | Warnings | 6DC9Q167V3 |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 Skin Protectant | GLYCERIN | L'Oreal USA Products Inc | 32eaaaab-41bd-4efe-a71d-92e3a702c1e5 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2023-12-11 | Warnings | PDC6A3C0OX |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 | GLYCERIN | Cosmetique Active Production | 01c8a0d5-bcd1-4639-be45-530a226401f0 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Loratadine | LORATADINE | A-S Medication Solutions | 0f6fe391-8709-40f0-8f52-e3357e6ea4f9 | 2023-12-09 | Warnings | 692783 7AJO3BO7QN |
| Loratadine Allergy Relief | LORATADINE | OHM LABORATORIES INC. | c35f2cc1-f76d-4824-b0a5-747bca0c3b85 | 2023-12-08 | Warnings | 7AJO3BO7QN |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| Hemorrhoidal Pain Relief Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | WALGREENS | 03bbe146-f185-bcfa-e063-6394a90a85bf | 2023-12-04 | Warnings | PDC6A3C0OX |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Bloop Hemorrhoid Relief Topical | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Three Nations Corp | 0b6419e3-f1c7-bdfe-e063-6294a90a5d92 | 2023-11-30 | Warnings | PDC6A3C0OX |
| All Day Allergy Relief | LORATADINE | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 7eac9202-bd4c-4550-a257-2b8195a0dbcd | 2023-11-29 | Warnings | 7AJO3BO7QN |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Saccharum officinale | SUCROSE | Boiron | 86d04552-b31a-0fcf-e053-2991aa0acecd | 2023-11-14 | C151H8M554 | |
| Saccharum officinale | SUCROSE | Boiron | 86d05561-6f09-6f1f-e053-2a91aa0a4b98 | 2023-11-14 | C151H8M554 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.